Tissue engineering to treat pelvic organ prolapse

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Gynecology

Background:

• Pelvic organ prolapse (POP) is a prevalent condition significantly impacting women's quality of life.
• Tissue engineering has emerged as a promising therapeutic avenue for POP treatment.
• Biological scaffolds are central to current research in POP management.

Purpose of the Study:

• To review recent advancements in tissue engineering for pelvic floor reconstruction.
• To identify and discuss challenges in scaffold design, cell selection, and growth factor utilization.
• To provide insights for future research and clinical applications in POP treatment.

Main Methods:

• Literature review of recent studies in tissue engineering for POP.
• Analysis of current challenges in scaffold fabrication and cell sourcing.
• Discussion of growth factor roles in pelvic floor tissue regeneration.

Main Results:

• Significant progress has been made in developing biological scaffolds for POP.
• Key challenges remain in optimizing scaffold properties, seed cell integration, and growth factor delivery.
• Tissue engineering approaches show potential for improved pelvic floor reconstruction.

Conclusions:

• Tissue engineering holds considerable promise for addressing the unmet needs in pelvic organ prolapse treatment.
• Further research is needed to overcome challenges in scaffold development, cell therapy, and growth factor application.
• Optimizing these components is crucial for successful pelvic floor reconstruction and enhanced patient outcomes.